Block Listing Six Monthly Return

RNS Number : 8593E

Oncimmune Holdings PLC

16 March 2022

 

16 March 2022

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Block Listing Six Monthly Return

Oncimmune makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements in respect of Oncimmune Holdings plc 2016 Unapproved and EMI Share Option Plans (the "Share Option Plans").

Name of applicant:	Oncimmune Holdings plc
Name of scheme:	Oncimmune Holdings plc 2016 Unapproved and EMI Share Option Plans
Period of return:	16 September 2021 to 15 March 2022
Balance of unallotted securities under scheme(s) from previous return:	5,805,745
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	0
Less: Number of securities issued/allotted under scheme(s) during period:	18,399
Equals: Balance under scheme(s) not yet issued/allotted at end of period:	5,787,346

For further information:

Oncimmune Holdings plc

Ron Kirschner, Company Secretary

[e-mail]

Singer Capital Markets (Nominated Adviser and Joint Broker)

Aubrey Powell, Harry Gooden, George Tzimas, James Fischer

[phone]

WG Partners (Joint Broker)

David Wilson, Nigel Barnes, Erland Sternby

[phone]

Media enquiries:

FTI Consulting

Ben Atwell, Michael Trace, Alex Davis

[e-mail]

[phone]

 

END

 

 

BLRUVAORUSUOAAR